Homeinvesting in biotech

investing in biotech

AXSM SHAREHOLDER ALERT: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Axsome Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – AXSM

AXSM SHAREHOLDER ALERT: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Axsome Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – AXSM

June 8, 2022

bluebird (BLUE) Up as FDA Nod Likely for Thalassemia Therapy

bluebird (BLUE) Up as FDA Nod Likely for Thalassemia Therapy

June 8, 2022

FDA Committee Proposes EUA Nod to Novavax’s (NVAX) COVID Jab

FDA Committee Proposes EUA Nod to Novavax’s (NVAX) COVID Jab

June 8, 2022

Mirati (MRTX) Up on Positive Data From NSCLC Study on Adagrasib

Mirati (MRTX) Up on Positive Data From NSCLC Study on Adagrasib

June 8, 2022

Why Is Amicus Therapeutics (FOLD) Up 25.1% Since Last Earnings Report?

Why Is Amicus Therapeutics (FOLD) Up 25.1% Since Last Earnings Report?

June 8, 2022

Bluebird (BLUE) Down 6.2% Since Last Earnings Report: Can It Rebound?

Bluebird (BLUE) Down 6.2% Since Last Earnings Report: Can It Rebound?

June 8, 2022

Why Is CRISPR Therapeutics AG (CRSP) Up 45.9% Since Last Earnings Report?

Why Is CRISPR Therapeutics AG (CRSP) Up 45.9% Since Last Earnings Report?

June 8, 2022

Apellis (APLS), Sobi Begin Pegcetacoplan Dosing in Kidney Disease

Apellis (APLS), Sobi Begin Pegcetacoplan Dosing in Kidney Disease

June 8, 2022

Bruker (BRKR) to Advance 4D Proteomics With Latest Launch

Bruker (BRKR) to Advance 4D Proteomics With Latest Launch

June 8, 2022

Sanofi’s (SNY) Dupixent Gets FDA Nod for Eczema in Infants

Sanofi’s (SNY) Dupixent Gets FDA Nod for Eczema in Infants

June 8, 2022

« 1 … 42 43 44 45 46 … 540 »